|Closed captioning will be available in English and Japanese for all keynotes and RSAC track sessions.
Please note: All times are in SGT.
It is critical to come to ground truth when high consequence vulnerabilities are discovered in medical devices. The FDA is exploring the development and viability of a Cyber Med Safety Analysis Board to integrate critical patient safety and clinical environment dimensions into the assessment and validation of high-risk/high-impact device vulnerabilities and incidents.
Pre-Requisites: Familiarity with medical devices and their use within the clinical environment; familiarity with the medical device regulatory environment.